Evidence map›Paper›PMID 42755864›Full record

ArticleFrontiers in endocrinology2026

Microbial metabolite-mediated modulation of enteroendocrine and immune pathways by

Carmen Veciana-Galindo, Eva Núñez-Delegido, Jorge González-Santos, Juan Agüera-Santos, Vicente Navarro-López, Ignacio Alberola-Jordá

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carmen Veciana-GalindoBiopartner SL, Alcoy, Alicante, Spain.
Eva Núñez-DelegidoResearch and Development Department, Bioithas SL, Alicante, Alicante, Spain.
Jorge González-SantosResearch and Development Department, Bioithas SL, Alicante, Alicante, Spain.
Juan Agüera-SantosResearch and Development Department, Bioithas SL, Alicante, Alicante, Spain.
Vicente Navarro-LópezResearch and Development Department, Bioithas SL, Alicante, Alicante, Spain.
Ignacio Alberola-JordáBiopartner SL, Alcoy, Alicante, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The gut microbiota-enteroendocrine axis contributes to the regulation of host energy homeostasis through microbial metabolites and satiety-related signaling. This study evaluated whether Methods: A dynamic multi-compartment colonic fermentation model was used to assess changes in cultivable microbial groups and short-chain fatty acid (SCFA) concentrations following probiotic treatment. Fermentation samples were subsequently evaluated in STC-1 enteroendocrine cells and a Caco-2/THP-1 co-culture model. In parallel, the metabolic and immunomodulatory effects of Results: Probiotic treatment selectively modulated cultivable microbial groups, increasing lactic acid bacteria and decreasing Discussion:

Indexed as

Diet, High-FatEnteroendocrine CellsGastrointestinal MicrobiomeLactobacillaceaeObesityProbioticsAnimalsCaco-2 CellsColonFatty Acids, VolatileFermentationHumansMaleMiceMice, Inbred C57BLFatty Acids, Volatileadipokinescolonic fermentationenteroendocrine signalingglucagon-like peptide-1high-fat dietimmunomodulationprobioticshort-chain fatty acids

Identifiers

PMID42755864
PMCPMC13581857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.